Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Nat Commun ; 14(1): 5208, 2023 08 25.
Artículo en Inglés | MEDLINE | ID: mdl-37626123

RESUMEN

Aberrant enhancer activation is a key mechanism driving oncogene expression in many cancers. While much is known about the regulation of larger chromosome domains in eukaryotes, the details of enhancer-promoter interactions remain poorly understood. Recent work suggests co-activators like BRD4 and Mediator have little impact on enhancer-promoter interactions. In leukemias controlled by the MLL-AF4 fusion protein, we use the ultra-high resolution technique Micro-Capture-C (MCC) to show that MLL-AF4 binding promotes broad, high-density regions of enhancer-promoter interactions at a subset of key targets. These enhancers are enriched for transcription elongation factors like PAF1C and FACT, and the loss of these factors abolishes enhancer-promoter contact. This work not only provides an additional model for how MLL-AF4 is able to drive high levels of transcription at key genes in leukemia but also suggests a more general model linking enhancer-promoter crosstalk and transcription elongation.


Asunto(s)
Leucemia , Proteínas Nucleares , Humanos , Proteínas Nucleares/genética , Factores de Transcripción/genética , Secuencias Reguladoras de Ácidos Nucleicos , Leucemia/genética , Regiones Promotoras Genéticas/genética , Proteínas de Ciclo Celular , Proteínas de Fusión Oncogénica/genética , Proteína de la Leucemia Mieloide-Linfoide/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA